Report Store | Pharma intelligence
  • My Account
    • 0Shopping Cart
  • $0.00
  • Disease analysis
    • Anemias
    • Bacterial infections
    • Bleeding disorders
    • Brain Cancer
    • Breast and gynecological cancer
    • Cardiovascular and Metabolic
    • Central Nervous System
    • Cerebrovascular diseases
    • Dermatology
    • Diabetes and diabetic complications
    • Gastroenterology
    • Gastrointestinal cancer
    • Head and Neck Cancer
    • Hypertension
    • Immunology and Inflammation
    • Infectious Diseases
    • Ischemic heart disease
    • Leukemia
    • Lung Cancer
    • Lymphoma
    • Oncology overview
    • Market Spotlight
    • Mens Health
    • Neurology
    • Oncology
    • Ophthalmology
    • Other Hematological Cancers
    • Other metabolic diseases
    • Other Solid Cancers
    • Pain
    • Psychiatry
    • Respiratory
    • Rheumatology
    • Skin cancer
    • Thrombosis
    • Urological cancer
    • Vaccines
    • Viral infections
    • Women’s Health
  • Strategy analysis
    • Bleeding disorders
    • Breast and gynecological cancer
    • Cardiovascular and Metabolic
    • Central Nervous System
    • Commercial Strategy
    • Dealmaking and R&D
    • Head and Neck Cancer
    • Hot Topics
    • Infectious Diseases
    • KOL Insight
    • Leukemia
    • Lung Cancer
    • Manufacturing
    • Market Access
    • Neurology
    • Oncology
    • Outsourcing
    • Pricing & Reimbursement
    • R&D
    • Regulatory & Therapeutic Area
    • Trends
    • Urological cancer
  • Company analysis
    • Big Pharma
    • Emerging Pharma
    • Hot Topics
    • Japan Pharma
    • M&A Analysis
    • Mid Pharma
  • Drug analysis
    • A
    • B-C
    • D-F
    • G-L
    • M-O
    • P-R
    • S-T
    • U-Z
  • MedTech analysis
    • Allergy
    • Autoimmune / Immunology
    • Cardiovascular
    • Dermatology
    • Endocrine
    • ENT / Dental
    • Gastroenterology
    • Hearing
    • Hematology
    • Infectious Diseases
    • Metabolic
    • Neurology
    • Obstetrics / Gynecology
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Osteoporosis
    • Psychiatry
    • Renal
    • Respiratory
    • Rheumatology
    • Urology
  • Opinion & analysis
    • Business Development
    • Business Management
    • Clinical Trials
    • Digital Health
    • Cybersecurity
    • Compliance & Risk
    • Digital patient management
    • Digital policy & regulation
    • Finance & Pricing
    • Healthcare Innovation
    • ICT and Health
    • Leadership
    • Legislation Regulation & Policy
    • Market Access
    • Market Intelligence
    • Medical
    • Pharmaceutical Device
    • Pharmaceutical Research
    • Strategy & Innovation
    • Tech companies & Data
    • Tech & Pharma
  • Blogs
  • Search
  • Menu
You are here: Home > MedTech analysis

MedTech analysis


  • Sort by Custom
    • Default
    • Custom
    • Name
    • Price
    • Date
    • Popularity (sales)
    • Average rating
    • Relevance
    • Random
    • Product ID
  • Click to order products descending
  • Display 45 Products per page
    • 15 Products per page
    • 30 Products per page
    • 45 Products per page
  • U.S. Markets for Cardiac Rhythm Management Products, February 2015

    $4,750.00

    Cardiac rhythm management (CRM) devices, which encompasses diagnostic and therapeutic systems, represents a well-established market that is still seeing innovation in some of the segments that compose it.

    February 2, 2015
    Find out more
  • U.S. Markets for Biologic and Tissue Engineered Devices – Cardiovascular and Neurological Products

    $3,750.00

    U.S. Markets for Biologic and Tissue Engineered Devices – Cardiovascular and Neurological Products, March 2015

    September 22, 2016
    Find out more
  • U.S. Markets for Anesthesia and Ventilation Products, February 2015

    $4,750.00

    A major driver of the U.S. anesthesia delivery systems market is the increase in surgical procedure volumes; this is largely due to the aging of the population, and will continue over the forecast period covered by this report.

    February 1, 2015
    Find out more
  • U.S. Markets for Advanced Wound Care Products

    $4,750.00

    U.S. Markets for Advanced Wound Care Products

    September 22, 2016
    Find out more
  • U.S. Disease Incidence and Prevalence

    $4,750.00

    This comprehensive report examines the etiology and epidemiology, number of hospital discharges, incidence and prevalence, and mortality rates of the most prevalent diseases/disorders in the United States for the years 2000-2010, and 2013.

    November 3, 2014
    Find out more
  • U.S. Cancer Statistics Update 2014

    $1,950.00

    This new report from Medtech Insight includes statistics for new cancer cases, prevalence, and deaths due to the disease in 2014.

    September 22, 2016
    Find out more
  • U.S. Benign Uterine Conditions Therapy Systems Market

    $3,750.00

    This report presents an overview of the most common types of treatment for the benign uterine conditions of menorrhagia and uterine fibroids/polyps; among these therapies are dilation and curettage, hysterectomy, hysteroscopy, and myomectomy. Market and competitive analyses for the medical devices used in these treatments also are presented.

    May 1, 2013
    Find out more
  • Type 1 Diabetes KOL Interview – US, Midwest

    $599.00

    This interview with a US Key Opinion Leader (KOL) provides insight into current therapies for type 1 diabetes, as well as pricing pressures within the diabetes market.

    January 8, 2020
    Find out more
  • Type 1 Diabetes KOL Interview – UK

    $599.00

    This interview with a UK Key Opinion Leader (KOL) provides insight into current therapies for type 1 diabetes.

    January 8, 2020
    Find out more
  • Triple-Negative Breast Cancer KOL Interview – UK

    $599.00

    A UK-based key opinion leader providers insights into prescribing habits, key marketed brands, and late-phase pipeline therapies for triple- negative breast cancer. Diagnostic testing, biomarker disease segmentation, and unmet needs are also discussed. Key pipeline assets highlighted include balixafortide, Keytruda, sacituzumab govitecan, trastuzumab deruxtecan, and veliparib.

    October 31, 2019
    Find out more
  • Transcatheter Heart Valve Repair and Replacement Devices

    Transcatheter Heart Valve Repair and Replacement Devices

    $4,750.00

    In 2020, the global market for transcatheter heart valve management products, including transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve (TMV) repair products, totaled nearly $4.7bn, with TAVR products accounting for nearly 90% of sales.

    August 30, 2021
    Find out more
  • Transcatheter Embolization and Occlusion Devices

    $4,750.00

    This comprehensive medical market and technology report provides an overview and in-depth market analysis of the global market for transcatheter embolization and occlusion devices.

    February 25, 2020
    Find out more
  • The Real Value of Medtech Markets: The impact of currency movements

    $2,995.00

    This report provides a comprehensive picture of the global medical orthopaedics market and relevant background, using the latest data and expert analysis. The report covers the top 160 markets by estimated US dollar value in 2019.

    November 27, 2019
    Find out more
  • The Global Molecular Diagnostics Market

    $6,250.00

    The molecular diagnostic products market is the highest growth segment of the global in vitro diagnostics (IVDs) market valued at an estimated $5.3 billion in 2014 and projected to grow at a compound annual growth rate of 6.6% to $7.3 billion by the year 2019.

    September 22, 2016
    Find out more
  • Surgical Procedure Volumes, US

    $4,750.00

    This report presents the most common surgical procedures performed in the United States (US) as well as an overview of the etiology and epidemiology of selected diseases/disorders, prevailing surgical approaches/techniques, and evolving procedural utilization trends.

    December 22, 2016
    Find out more
  • Surgical Heart Valve Repair and Replacement Devices

    $4,750.00

    This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the surgical heart valve repair (annuloplasty) systems and surgical heart valve replacement products markets for the US, 5 Euro (France, Germany, Italy, Spain, and UK), Japan, and Rest of World markets from 2020–25.

    June 28, 2021
    Find out more
  • Surgical Heart Valve Management Products

    $4,750.00

    This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the surgical heart valve repair (annuloplasty) systems, surgical heart valve replacement products, and percutaneous balloon valvuloplasty (PBV) systems markets.

    May 16, 2019
    Find out more
  • Spinal Motion Preservation Devices Market

    Spinal Motion Preservation Devices Market

    $4,750.00

    Sales of spinal motion preservation devices totaled $1.7bn in 2019, with sales expected to climb at a CAGR of 2.0% during 2019-2024.

    May 18, 2022
    Find out more
  • Spinal Fusion: Implanted Instrumentation

    $4,750.00

    Sales of implanted instrumentation for spinal fusion procedures totaled approximately $4.4bn in 2019, with sales expected to climb at a CAGR of 2.2% through 2024. Growth in the spinal fusion instrumentation market is being driven by several factors including the prevalence of degenerative disc disease, new surgical techniques and associated instrumentation that have expanded the range of product indications, and the launch of new enabling technology such as diagnostic, nerve monitoring, and navigation systems (including robotic-assisted surgery).

    August 20, 2020
    Find out more
  • Spinal Fusion Implanted Instrumentation Market

    $599.00

    This medical market and technology report provides a comprehensive discussion of implanted instrumentation for spinal fusion.

    February 28, 2018
    Find out more
  • Spinal Cord Stimulation Devices Market

    $4,750.00

    The large and burgeoning global market for implantable neurostimulation devices is approaching nearly $4 billion worldwide.  Despite lingering economic uncertainty and financial constraints that have affected many other medical device markets, this market is undergoing significant technological advancement due to heavy R&D and investment efforts by dozens of innovative startups and leading medical device companies.

    April 25, 2018
    Find out more
  • Specialty Endoscopic Surgery Devices Market

    $4,750.00

    The global market for specialty endoscopic surgery products totaled approximately $5.8bn in 2016, with the US comprising 48.2% of sales (or $2.8bn). Six major product segments are included in the specialty endoscopic surgery products market: endoscopes and equipment; suction/irrigation and fluid management systems, arthroscopic hand instruments, ENT/neurologic hand instruments, thoracoscopic hand instruments, and trocars.

    August 23, 2017
    Find out more
  • Specialty Endoscopic Surgery Devices – July 2019

    $4,750.00

    This Meddevicetracker report provides an analysis of the market for specialty endoscopic surgery devices (including access devices, endoscopes and equipment, hand instruments, and suction/irrigation and fluid management systems). Geographic segments covered include the US, five major EU markets, Japan, and the rest of the world.

    July 3, 2019
    Find out more
  • Spain, Surgical Procedure Volumes

    $4,850.00

    This report presents an overview of selected medical specialties and the number of surgical procedures performed for selected diseases/disorders in the European Union country of Spain.

    November 1, 2013
    Find out more
  • Spain, Neurological Market Opportunities: Disease Incidence and Prevalence, And Surgical Procedure Volumes

    $1,995.00

    This report presents the disease incidence and prevalence and surgical procedure volumes for selected neurological diseases/disorders and procedures in Spain

    December 3, 2012
    Find out more
  • Spain, Musculoskeletal Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes

    $1,995.00

    This report presents the disease incidence and prevalence and surgical procedure volumes for selected musculoskeletal disorders and procedures in Spain; incidence and prevalence figures are compared with those of the Benelux countries

    November 1, 2012
    Find out more
  • Robotically Assisted Surgical Devices Market

    $4,750.00

    This comprehensive medical market and technology report provides an analysis and sales forecast for the global market for robotically assisted surgical (RAS) systems.

    May 25, 2021
    Find out more
  • Respiratory Care: Noninvasive Ventilation and Airway Management Products

    $4,750.00

    Asthma and COPD, the two most prevalent respiratory diseases, affect nearly 600 million people worldwide, with annual mortality rates exceeding 3 million for COPD and 400,000 for asthma. COVID-19 has infected more than 60 million people worldwide, resulting in 1.5 million deaths. This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the positive airway pressure (PAP)-based noninvasive ventilation (NIV) and airway management products market, including CPAP and BiPAP devices as well as heat/moisture exchangers (HMEs), humidifiers, and nebulizers (including large- and small-volume nebulizers and nebulizer compressors).

     

    December 17, 2020
    Find out more
  • Respiratory Care: Mechanical Ventilators and Pulmonary Function Testing Systems

    $4,750.00

    Asthma and COPD affect an estimated 590 million people worldwide, with an additional 114 million affected by COVID-19 from March 2020 to March 2021. Devices used in the diagnosis and treatment of these and other respiratory disorders include mechanical ventilators and pulmonary function testing systems.

    March 30, 2021
    Find out more
  • Q4 2017 Meddevicetracker Outlook Report

    $4,750.00

    In this report, we cover catalysts from 9 devices expected to occur in Q4 2017, along with an overview of selected presentations from the upcoming Transcatheter Cardiovascular Therapeutics (TCT) Conference. The last page of this report contains an excel sheet of the Large Impact Catalysts expected to occur in Q4 2017.

    October 2, 2017
    Find out more
  • Q3 2021 Outlook Report

    Q3 2021 Outlook Report

    $4,750.00

    In this report, we cover catalysts from 27 drugs, devices, diagnostics, and deals expected to occur in the third quarter of 2021. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided. These data points were provided using a combination of Pharmapremia, Informa’s drug development benchmarking product utilizing Biomedtracker’s LOA data to assist in informed decisions about drug pipeline prioritization, partnerships, and acquisitions, and drug approval data from Biomedtracker.

    June 2, 2021
    Find out more
  • Q2 2017 Meddevicetracker Outlook Report

    $4,750.00

    Our Early 2017 Outlook Report highlighted several high-impact catalysts. In this report, we cover catalysts from 14 devices expected to occur in Q2 2017.

    March 31, 2017
    Find out more
  • Pulse Oximetry Devices Market

    $3,000.00

    This report provides an overview of pulse oximetry, and profiles selected leading products and technologies. The report also provides a market and competitive analysis of the global pulse oximetry devices market, including five-year market forecast and share by supplier.

    December 22, 2017
    Find out more
  • Prostate Cancer Diagnostics and Minimally Invasive Treatments Market

    Prostate Cancer Diagnostics and Minimally Invasive Treatments Market

    $4,750.00

    This comprehensive medical market and technology report provides an overview and in-depth market analysis of selected next-generation prostate cancer diagnostics, biopsy, and minimally invasive treatments.

    May 4, 2022
    Find out more
  • Point of Care Diagnostics

    $4,750.00

    Point of care in vitro diagnostics is being applied to an increasingly wide range of applications in infectious disease, cardiovascular, respiratory, and metabolic disease diagnosis and screening. The market is undergoing rapid expansion, primarily due to the demand for COVID-19 testing; however, other product segments will also contribute to market growth during the forecast period.

    June 28, 2021
    Find out more
  • PD-1/L1 Immunotherapies: Historical Sales and Market Trend Analysis Report

    $7,500.00

    Bristol-Myers Squibb’s (BMS) Opdivo (nivolumab) has outpaced Merck’s Keytruda (pembrolizumab) primarily
    in non-small cell lung cancer (NSCLC) because of its early approval in squamous NSCLC, updated National
    Comprehensive Cancer Network (NCCN) guidelines in 2015,

    December 22, 2016
    Find out more
  • Pain Management Devices Market

    Pain Management Devices Market

    $4,750.00

    This comprehensive medical market and technology report provides an overview of the medical devices (eg, electrical stimulators and analgesia infusion pumps) used in the management of chronic pain, and includes an in-depth market analysis. This global report covers the US, European, and Rest of World (RoW) markets.

    The report provides the following useful information:

    • pain management overview
    • key statistics on pain prevalence in major world regions
    • medical device product portfolios offered by leading manufacturers
    • top selling products, as well as emerging products under development
    • in-depth market and competitive analyses

    Medical devices covered in this report include:

    • electrical nerve stimulators (transcutaneous electrical nerve stimulators [TENS] and neurostimulation products including spinal cord stimulators [SCSs], discussed in Chapter 2)
    • analgesia infusion pumps and accessories (implantable analgesia infusion pumps and external analgesia infusion pumps, discussed in Chapter 3)
    June 1, 2017
    Find out more
  • Orthobiologics Market for Musculoskeletal Soft Tissue Replacement and Regeneration

    $4,750.00

    This report provides an analysis and sales forecast for the global market for orthobiologics for musculoskeletal soft tissue replacement and regeneration. Market segments covered in this report include:

    July 20, 2017
    Find out more
  • Orthobiologics for Musculoskeletal Soft Tissue Replacement and Regeneration – 2021

    $4,750.00

    This medical market and technology report provides a comprehensive discussion of the global market for orthobiologics for musculoskeletal soft tissue replacement and regeneration. Geographic markets covered by this analysis comprise the US, Japan, five major European markets (France, Germany, Italy, Spain, and the UK), and the rest of world (RoW), which includes all other countries.

    November 2, 2021
    Find out more
  • Orthobiologics for Musculoskeletal Soft Tissue Replacement and Regeneration

    $4,750.00

    This medical market and technology report provides a comprehensive discussion of the global market for orthobiologics for musculoskeletal soft tissue replacement and regeneration (including cell-based therapies and tissue scaffolds and grafts). Geographic markets covered by this analysis include the US, Japan, five major EU markets (France, Germany, Italy, Spain, and the UK), and the Rest of World (RoW), which includes all other countries.

    October 11, 2019
    Find out more
  • Orthobiologics for Bone Repair and Regeneration

    $4,750.00

    Sales of orthobiologics for the repair and regeneration of bone totaled nearly $2.4bn in 2018, with sales expected to climb at a CAGR of 3.2% through 2024. Growth in this market will be driven by the aging of the population and the global burden of musculoskeletal disease.

    March 5, 2020
    Find out more
  • Ophthalmic Surgical Products Market

    Ophthalmic Surgical Products Market

    $4,750.00

    At $9.1bn, the ophthalmic surgical products market is one of the largest medical device markets globally, and serves an important need: preventing blindness for millions of people who suffer from cataracts, glaucoma, vitreoretinal disease, and refractive errors.

    December 8, 2021
    Find out more
  • Oncology: Surgical Ablation Devices Market

    $4,750.00

    Valued at approximately $380m in 2017, the Surgical Ablation Devices Market for Oncology is expanding at a double-digit rate, driven by the increasing global prevalence of cancer and the growing demand for better healthcare in emerging markets.

    June 19, 2018
    Find out more
  • Oncology: Liquid Biopsy Products

    $4,750.00

    This report provides analysis of the global market for liquid biopsy products for the diagnosis and management of cancer. Regions covered by this report include North America, Europe, Asia Pacific, and the rest of the world (which combines estimated sales data for all other countries).

    August 9, 2018
    Find out more
  • Neuromodulation: Spinal Cord Stimulation Devices Market

    Neuromodulation: Spinal Cord Stimulation Devices Market

    $4,750.00

    According to a recent CDC study, 20.1% of adults had chronic pain and 7.4% of adults had chronic pain that frequently limited life or work activities with similar numbers being reported in Europe. In 2021, the spinal cord stimulation (SCS) devices market was worth nearly $2.9 bn. Market drivers of the SCS devices market through 2026 will be driven by an aging population and an increase in selected conditions (eg back/leg pain, and a growing number of indications) that result in debilitating and unrelenting chronic pain.

    February 22, 2022
    Find out more
Page 2 of 5
Page 2 of 512345
  • Home
  • Terms and Conditions
  • Refund policy
  • Privacy Policy
  • Cookie Policy
  • Contact Us
  • About Us
  • Discounts
  • Market Spotlight – Reports
  • twitter
  • linkedin
  • Sitemap
Copyright © 2022 Pharma Intelligence UK Limited Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is Suite 1, 3rd Floor, 11 - 12 St. James's Square, London, England, SW1Y 4LB. Pharma Intelligence UK Limited is part of the Pharma Intelligence Group.

Sign up to the Pharma Intelligence Report Store Newsletter to get the latest blogs, news, reports and discounts!

Pharma Intelligence
This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.
Call Back
Scroll to top